European Agency to Investigate HPV Vaccines

Don’t celebrate yet.

Who does the EMA turn to in order to investigate these potential safety concerns?

Believe it, or not – In order to examine potential safety concerns with Gardasil/Silgard, Gardasil 9 and Cervarix the Pharmacovigilance Risk Assessment Committee (PRAC) is going to question the Marketing Authorization Holders (MAH’s). The Marketing authorisation holders for these products are GlaxoSmithKline Biologicals, Merck Sharp & Dohme Limited, and Sanofi Pasteur MSD.

How insane can one get? These are the very organizations which stand to lose the most should a safety issue be proven regarding HPV vaccines. Does anyone in their right mind think these organizations are going to be transparent when it comes to anything that could substantially effect their bottom line?

So, what hope do thousands of affected families have? In this particular instance, there is a great deal of hope. The EMA may have been able to conduct their investigations like this in the past. This time it will not work.

Parents of those with new medical conditions after HPV vaccine administration are not isolated and alone. They have united around the world. They do not want further clarification – they want the truth. They are watching.